In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

[Q]: 340B Program Improvement Act - Amends the Public Health Service Act to make revisions to the 340B drug discount program (a program limiting the cost of covered outpatient drugs to certain federal grantees).

Includes drugs used in connection with an inpatient or outpatient service by enrolled hospitals as covered drugs under the program (currently, only outpatient drugs are covered under the program).

Requires hospitals enrolled in the 340B program to provide to each state a credit on the estimated annual purchases by such hospitals of covered drugs provided to Medicaid recipients for inpatient use. Sets forth a formula for calculating the credit. Allows a hospital to avoid paying such credits under certain circumstances.

Eliminates the requirement that hospitals enrolled in the 340B program report the National Drug Code numbers for drugs administered by a physician if the state is precluded from seeking a rebate on such drugs because they were purchased at a discount under the 340B program.

Removes the exclusion that prohibited covered entities added to the 340B program under the Patient Protection and Affordable Care Act from purchasing drugs for a rare disease or condition as covered outpatient drugs.

Treats a facility or organization that is eligible for the 340B program as satisfying any geographic location requirements in relation to a hospital or a critical access hospital for purposes of determining provider-based status under Medicare.
[A]: To amend section 340B of the Public Health Service Act to improve the provision of discounts on drug purchases for certain safety net providers.


[Q]: Stabilization and Pacification of Southern Serbia Act - Declares it is U.S. policy to: (1) promote dialog between representatives of the Albanian community of southern Serbia and the authorities of the Republic of Serbia and the Federal Republic of Yugoslavia aimed at addressing the concerns of both the ethnic Albanian residents of the region and those of the Serbian authorities; (2) address the deteriorating security situation in the Presevo valley of southern Serbia in conjunction with the North Atlantic Treaty Organization (NATO), the NATO-led international security force for Kosovo (KFOR), and the Serbian authorities; (3) urge the authorities of Yugoslavia and Serbia to work with the Government of the Former Yugoslav Republic of Macedonia to find agreement on a demarcation of the border between Serbia and Macedonia; (4) support efforts of Yugoslavia, Serbia, and Macedonia to maintain security along the agreed upon border; and (5) oppose any modification of the political status of the Province of Kosovo unless and until all ethnically motivated violence by Kosovo Albanians against Serbian residents of Kosovo has subsided, and all assistance by Kosovo residents to parties using violent means to further separatist aims in southern Serbia or Macedonia has ceased.Prohibits the expenditure of certain economic support fund assistance (not including international narcotics control and law enforcement funds) for Kosovo after June 30, 2001, unless the President certifies to Congress that all concerned parties are taking steps to end the ethnically-motivated violence in southern Serbia, Kosovo, and Macedonia. Authorizes the President to waive the requirements of this Act if it is in the national interests of the United States.
[A]: To prohibit assistance for Kosovo unless the President determines and certifies to Congress that residents or citizens of Kosovo are not providing assistance to organizations engaging in or otherwise supporting ethnically-motivated violence in southern Serbia or in Macedonia, and for other purposes.


[Q]: Preservation of Antibiotics for Medical Treatment Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to deny an application for a new animal drug that is a critical antimicrobial animal drug unless the applicant demonstrates that there is a reasonably certainty of no harm to human health due to the development of antimicrobial resistance attributable to the nontherapeutic use of the drug. Defines "critical antimicrobial animal drug" as a drug intended for use in food-producing animals that contains specified antibiotics or other drugs used in humans to treat or prevent disease or infection caused by microorganisms.

Requires the Secretary to withdraw approval of a nontherapeutic use of such drugs in food-producing animals two years after the date of enactment of this Act unless certain safety requirements are met.

Requires the manufacturer of such a drug or an animal feed for food-producing animals containing such a drug to report sales information to the Secretary.
[A]:
To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.